7. Bibliografía
Chapple CR, Nitti VW, Khullar V, Wyndaele JJ, Herschorn S, van Kerrebroeck P, et al. Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World J Urol 2014;32(6):1565–1572. Shamliyan T, Wyman JF, Ramakrishnan R, Sainfort F, Kane RL. Benefits and Harms of Pharmacologic Treatment …